SNDX
Syndax Pharmaceuticals Inc
18.20$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Syndax Pharmaceuticals Inc (SNDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -323 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 | -9.3 | -7.3 | -14 | -2.4 | -35 | -47 | -69 | -51 | -71 | 29 | -134 | -161 | -275 | -323 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 0.1 | 1.4 | 2.3 | 3.9 | 4.7 | 5.5 | 6.2 | 6.0 | 9.1 | 13 | 16 | 31 | 43 | 48 | |
| – | – | – | 0.5 | 6.3 | 6.3 | 5.7 | 6.2 | 6.0 | 9.4 | 13 | 14 | – | – | – | |
| 0.1 | 0.8 | 0.0 | 0.6 | 15 | 2.9 | 7.7 | -0.3 | -0.2 | -7.9 | -9.6 | 1.7 | 32 | 13 | -79 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | |
| 2.2 | 0.5 | -4.0 | 1.9 | -62 | -18 | -17 | 51 | 13 | -143 | -41 | -186 | 118 | -220 | 290 | |
| – | – | – | – | – | 2.6 | – | – | – | – | – | – | – | – | – | |
| – | – | – | 0.0 | 88 | 54 | 27 | 16 | 29 | 285 | 25 | – | – | – | – | |
| – | – | – | 14 | -9.0 | – | 20 | 20 | 20 | 20 | -21 | -21 | 0.0 | 0.0 | – | |
| 8.6 | 5.7 | 21 | 12 | 77 | 54 | 76 | 16 | 29 | 304 | 118 | 172 | 264 | 353 | 14 | |
| – | -3.1 | 9.6 | -0.1 | 13 | 0.7 | 11 | -1.4 | -9.3 | 91 | 107 | -148 | 221 | -141 | -19 | |
| -10 | -9.3 | -7.3 | -14 | -2.5 | -35 | -47 | -69 | -51 | -71 | 29 | -134 | -161 | -275 | -323 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.